Nyxoah SA (NYXH) NPV

Sell:€9.80Buy:€10.20€0.08 (0.80%)

Prices delayed by at least 15 minutes
Sell:€9.80
Buy:€10.20
Change:€0.08 (0.80%)
Deal now
Prices delayed by at least 15 minutes
Sell:€9.80
Buy:€10.20
Change:€0.08 (0.80%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Key people

Olivier Taelman
Chief Executive Officer, Executive Director
John Landry
Chief Financial Officer
Loic Moreau
President - International
Maurits S. Boon
Chief Medical Officer
Christoph Eigenmann
Chief Commercial Officer
Scott Holstine
Chief Commercial Officer
Francis Kim
Chief Regulatory and Quality Officer
Robert Taub
Non-Executive Chairman of the Board
Pierre Gianello
Non-Executive Director
Virginia Kirby
Independent Director
Juergen Hambrecht
Non-Executive Independent Director
Rita F. Johnson-Mills
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Belgium
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    BE0974358906
  • Market cap
    €374.27m
  • Employees
    147
  • Shares in issue
    37.43m
  • Exchange
    Euronext Brussels
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.